FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2095902657> ?p ?o ?g. }

• W2095902657 endingPage "187" @default.
• W2095902657 startingPage "179" @default.
• W2095902657 abstract "Inflammatory bowel disease (IBD) is a condition of the intestine with significant morbidity. Although hereditary, environmental, immunologic, and bacterial factors have been implicated, the etiology of IBD remains unknown. Since opioid peptides modulate inflammatory cytokine production and opioid antagonists promote tissue growth and repair, we hypothesized the opioid antagonist naltrexone could reduce inflammation of the bowel. Using a chemically-induced mouse model of IBD, C57BL/6J mice received either untreated drinking water or water containing 2% dextran sulfate sodium (DSS) in two parallel regimens modeling moderate and severe colitis. After colitis was established, animals in the moderate colitis study were administered either saline (control) or naltrexone (NTX; 8 or 400 μ g/kg) daily, while those in the severe colitis study received 0.1 or 10 mg/kg NTX. DSS-treated animals had significant weight loss (p = 0.006) and higher disease activity index (DAI) scores (p < 0.001) compared to water controls. However, NTX treatment of mice with moderate colitis resulted in less weight loss, lower DAI scores, and less histologic evidence of inflammation compared to controls. Significantly, elevated levels of colonic RNA for pro-inflammatory cytokines interleukin (IL)-6 and IL-12 were also decreased toward normal with NTX. Similar to patients with severe and unresponsive disease, animals in the severe colitis study did not significantly respond to treatment. Thus, NTX therapy reverses physical symptoms, histologic evidence, and molecular markers of inflammation in moderate colitis. The mechanism by which NTX acts to reverse colitis is related in part to the decreased expression of pro-inflammatory cytokines." @default.
• W2095902657 created "2016-06-24" @default.
• W2095902657 creator A5024301218 @default.
• W2095902657 creator A5025034153 @default.
• W2095902657 creator A5027382068 @default.
• W2095902657 creator A5034246102 @default.
• W2095902657 creator A5063328571 @default.
• W2095902657 creator A5076398741 @default.
• W2095902657 creator A5084391269 @default.
• W2095902657 date "2008-01-01" @default.
• W2095902657 modified "2023-10-03" @default.
• W2095902657 title "The Opioid Antagonist Naltrexone Improves Murine Inflammatory Bowel Disease" @default.
• W2095902657 cites W1855226200 @default.
• W2095902657 cites W1965117083 @default.
• W2095902657 cites W1965614926 @default.
• W2095902657 cites W1968666033 @default.
• W2095902657 cites W1978095676 @default.
• W2095902657 cites W1982869820 @default.
• W2095902657 cites W1991617110 @default.
• W2095902657 cites W2002642921 @default.
• W2095902657 cites W2003356209 @default.
• W2095902657 cites W2012162544 @default.
• W2095902657 cites W2014663340 @default.
• W2095902657 cites W2028158224 @default.
• W2095902657 cites W2030298985 @default.
• W2095902657 cites W2032158136 @default.
• W2095902657 cites W2034217591 @default.
• W2095902657 cites W2035681584 @default.
• W2095902657 cites W2038535814 @default.
• W2095902657 cites W2040936681 @default.
• W2095902657 cites W2042186192 @default.
• W2095902657 cites W2043000199 @default.
• W2095902657 cites W2050693965 @default.
• W2095902657 cites W2066906665 @default.
• W2095902657 cites W2076519131 @default.
• W2095902657 cites W2076838466 @default.
• W2095902657 cites W2092316340 @default.
• W2095902657 cites W2093608501 @default.
• W2095902657 cites W2099376515 @default.
• W2095902657 cites W2101302288 @default.
• W2095902657 cites W2112340015 @default.
• W2095902657 cites W2116093385 @default.
• W2095902657 cites W2133711077 @default.
• W2095902657 cites W2136190342 @default.
• W2095902657 cites W2148298419 @default.
• W2095902657 cites W2150769574 @default.
• W2095902657 cites W2153211079 @default.
• W2095902657 cites W2158427090 @default.
• W2095902657 cites W2201597212 @default.
• W2095902657 cites W2321453230 @default.
• W2095902657 cites W4253384824 @default.
• W2095902657 doi "https://doi.org/10.1080/15476910802131469" @default.
• W2095902657 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18569389" @default.
• W2095902657 hasPublicationYear "2008" @default.
• W2095902657 type Work @default.
• W2095902657 sameAs 2095902657 @default.
• W2095902657 citedByCount "22" @default.
• W2095902657 countsByYear W20959026572013 @default.
• W2095902657 countsByYear W20959026572014 @default.
• W2095902657 countsByYear W20959026572015 @default.
• W2095902657 countsByYear W20959026572016 @default.
• W2095902657 countsByYear W20959026572017 @default.
• W2095902657 countsByYear W20959026572018 @default.
• W2095902657 countsByYear W20959026572019 @default.
• W2095902657 countsByYear W20959026572020 @default.
• W2095902657 countsByYear W20959026572021 @default.
• W2095902657 countsByYear W20959026572022 @default.
• W2095902657 countsByYear W20959026572023 @default.
• W2095902657 crossrefType "journal-article" @default.
• W2095902657 hasAuthorship W2095902657A5024301218 @default.
• W2095902657 hasAuthorship W2095902657A5025034153 @default.
• W2095902657 hasAuthorship W2095902657A5027382068 @default.
• W2095902657 hasAuthorship W2095902657A5034246102 @default.
• W2095902657 hasAuthorship W2095902657A5063328571 @default.
• W2095902657 hasAuthorship W2095902657A5076398741 @default.
• W2095902657 hasAuthorship W2095902657A5084391269 @default.
• W2095902657 hasConcept C126322002 @default.
• W2095902657 hasConcept C170493617 @default.
• W2095902657 hasConcept C203014093 @default.
• W2095902657 hasConcept C2775862500 @default.
• W2095902657 hasConcept C2775962371 @default.
• W2095902657 hasConcept C2776914184 @default.
• W2095902657 hasConcept C2777972943 @default.
• W2095902657 hasConcept C2778260677 @default.
• W2095902657 hasConcept C2778690821 @default.
• W2095902657 hasConcept C2778750930 @default.
• W2095902657 hasConcept C2779134260 @default.
• W2095902657 hasConcept C2781063702 @default.
• W2095902657 hasConcept C71924100 @default.
• W2095902657 hasConcept C90924648 @default.
• W2095902657 hasConceptScore W2095902657C126322002 @default.
• W2095902657 hasConceptScore W2095902657C170493617 @default.
• W2095902657 hasConceptScore W2095902657C203014093 @default.
• W2095902657 hasConceptScore W2095902657C2775862500 @default.
• W2095902657 hasConceptScore W2095902657C2775962371 @default.
• W2095902657 hasConceptScore W2095902657C2776914184 @default.
• W2095902657 hasConceptScore W2095902657C2777972943 @default.
• W2095902657 hasConceptScore W2095902657C2778260677 @default.

• next